Authors : Mansi M. Gajbhiye

Volume/Issue : Volume 11 - 2026, Issue 1 - January

Google Scholar : https://tinyurl.com/27pdyyxp

Scribd : https://tinyurl.com/bdfbbnvp

DOI : https://doi.org/10.38124/ijisrt/26jan112

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia and is associated with the progressive development of microvascular and macrovascular complications. Despite the availability of conventional antidiabetic therapies, long-term management of diabetes-related complications remains a major clinical challenge due to adverse effects and limited efficacy. In recent years, medicinal plants have gained increasing attention as complementary therapeutic options owing to their safety profile and multi-targeted actions. Moringa oleifera, commonly known as the drumstick tree, has emerged as a promising medicinal plant with diverse pharmacological properties. Beyond its glucose- lowering potential, Moringa oleifera exhibits antioxidant, anti-inflammatory, nephroprotective, neuroprotective, retinoprotective, and wound-healing activities that are relevant to the management of diabetic complications. The therapeutic effects of Moringa oleifera are attributed to its rich phytochemical composition, including flavonoids, phenolic acids, vitamins, and bioactive glycosides. This review comprehensively discusses the role of Moringa oleifera in targeting major diabetic complications such as diabetic retinopathy, nephropathy, neuropathy, and impaired wound healing. Additionally, the underlying mechanisms of action and recent experimental and clinical evidence supporting its therapeutic potential are highlighted. Overall, Moringa oleifera represents a valuable natural candidate for adjunctive therapy aimed at preventing and managing diabetes-associated complications beyond glycemic control.

Keywords : Moringa Oleifera, Diabetes Mellitus, Diabetic Complications, Oxidative Stress, Herbal Medicine.

References :

1. 1. Mthiyane, F. T., et al. (2024). A review on the antidiabetic properties of Moringa oleifera extracts: focusing on oxidative stress and inflammation. Molecules, 29(10): 2237.https://pubmed.ncbi.nlm.nih.gov/35899107/
   2. Daba, M. (2020). Nutritional composition and antioxidant properties of Moringa oleifera. Asian Pac J Trop Biomed 8(7): 289-297. https://pubmed.ncbi.nlm.nih.gov/39849793/
   3. Sidney JS, Michael JH; First published: 24 March 2015; Review of the Safety and Efficacy of Moringa oleifera ;Volume 29 page no. 796-804. https://doi.org/10.1002/ptr.5325
   4. Leone, A., et al. (2015). Nutritional properties and antioxidant capacity of moringa powders. Phytotherapy Research, 29(3): 295–305. https://pubmed.ncbi.nlm.nih.gov/25620073/
   5. Gupta, R., et al. (2020). Anti-diabetic and antioxidant activities of Moringa oleifera leaves: an overview of evidence. Phytomedicine, 68: 153217.https://pubmed.ncbi.nlm.nih.gov/32035982/
   6. Vergara-Jimenez, M., et al. (2017). Bioactive components in Moringa oleifera leaves protect against chronic disease. Antioxidants, 2(4): 189–210.https://pubmed.ncbi.nlm.nih.gov/28684661/
   7. Saini, R. K., et al. (2016). Nutritional, therapeutic, and processing aspects of Moringa oleifera leaves. Front Pharmacol, 7:32. https://pubmed.ncbi.nlm.nih.gov/27089374/
   8. Gopalakrishnan, L., et al. (2016). Miracle tree: review on nutritional and medicinal properties of Moringa oleifera. Food Science and Human Wellness, 5(2): 49–56. https://doi.org/10.1016/j.fshw.2016.04.001
   9. Fuglie, L. (1999). The Miracle Tree: Leaves of Moringa oleifera. Dakar:Church World Service.
   10. 10.Jaiswal, D., et al. (2009). Hypoglycemic and antihyperglycemic effect of M. oleifera Lam. Indian J Clin Biochem, 24(1): 88–95. https://pubmed.ncbi.nlm.nih.gov/23105989/
   11. Mbikay, M. (2012). Therapeutic potential of Moringa oleifera leaves in chronic hyperglycemia. Int J Food Sci Nutr, 13(1): 1-7. https://pubmed.ncbi.nlm.nih.gov/22499423/
   12. Tende, J., et al. (2012). Hypoglycemic effects of Moringa oleifera leaf extract. Acta Vet Brno, 81: 349–353. https://pubmed.ncbi.nlm.nih.gov/26344723/
   13. Ndong, M., et al. (2007). Effects of Moringa oleifera leaf powder on glucose tolerance. Journal of Food Science and Technology, 42(1): 10–15. https://pubmed.ncbi.nlm.nih.gov/19070160/
   14. Trimigno, L., et al. (2020). Clinical evidence on moringa and metabolic syndrome. Nutrients, 12(7). https://www.mdpi.com/2072-6643/12/7/2050
   15. Kumbhare, D. M., et al. (2021). Animal studies show benefits of moringa on glucose metabolism. J Food Sci Technol, 58: 123.
   16. Bais, S., et al. (2023). Moringa oleifera extract ameliorates diabetic retinopathy via oxidative stress inhibition. Journal of Ethnopharmacology, 302: 115000. https://www.sciencedirect.com/science/article/abs/pii/S0254629923005720
   17. Batiha, G., et al. (2021). Antioxidant properties of Moringa in prevention of diabetic retinopathy. Biomedicine & Pharmacotherapy, 138: 111452.
   18. Ahmad, S., et al. (2024). Protective effect of M. oleifera against diabetic nephropathy. Phytochemistry Reviews. https://link.springer.com/article/10.1007/s11101-024-09927-x
   19. Aja, P. M., et al. (2014). Renoprotective effect of Moringa oleifera leaves in diabetic rats. Int J Biochem Res Rev, 5(1): 83–90.
   20. Iqbal, S., et al. (2023). Neuroprotective effects of M. oleifera in diabetic rats. Biomedicines, 13(3): 634. https://www.mdpi.com/2227-9059/13/3/634
   21. Aslam, M., et al. (2023). Moringa oleifera in wound healing and angiogenesis. Biomedical Journal of Scientific and Technical Research, 50(5): 39990. https://biomedres.us/fulltexts/BJSTR.MS.ID.008249.php
   22. MAYFIELD J ,1998; Classification of Diabetes mellitus, Volume 58(6):page no.1355-1362.
   23. Schuster DP, Duvuuri V; Diabetes Mellitus, Volume 19 , Issue 1,Pages 1193, January 2002.
   24. Anwar F, Latif S, Ashraf M, and Gilani AH, 2007; Moringa oleifera: a food plant with multiple medicinal uses. Phytotherapy Research; Volume 21(1): page no.17-25.
   25. Abdulkadir, A. R., et al. (2019). Moringa extract stimulated wound healing in diabetic rats. J Diabetes Metab Disord, 18: 129–138.
   26. ADA. (2021). Classification and Diagnosis of Diabetes. Diabetes Care, 44(Suppl 1): S15–S33.
   27. American Diabetes Association. Standards of care in diabetes. Diabetes Care, 45(Suppl1).
   28. DeFronzo, R. A. (2009). Pathogenesis of type 2 diabetes mellitus. Diabetes, 58(4): 773–795.
   29. Nathan, D. M. (2015). Diagnosis of diabetes. Lancet, 386: 1463–1464.
   30. Brownlee, M. (2005). The pathobiology of diabetic complications. Nature, 414(6865): 813–820.
   31. Forbes, J., et al. (2008). Oxidative stress and diabetic complications. Pharmacol Rev, 60(1): 144–175.
   32. Klein, R., et al. (2008). Epidemiology of diabetic retinopathy. Diabetes Care, 31: 190–191.
   33. Fioretto, P., et al. (2010). Diabetic nephropathy: microvascular complications. N Engl J Med, 370: 2294–2303.
   34. Tesfaye, S., et al. (2010). Neuropathy in diabetes. Lancet Neurology, 9:521–534.
   35. Saini, R. K., et al. (2014). Moringa phytoconstituents: Pharmacological profile. J Food Sci Technol, 51: 214–230.
   36. Anwar, F., et al. (2007). Moringa: A food plant with multiple medicinal uses. Phytotherapy Research, 21: 17–25.
   37. Coppin, J. P., et al. (2013). Micronutrients in Moringa oleifera. Journal of Food Composition and Analysis, 30: 107–112.
   38. Gupta, S., et al. (2012). Mechanisms of Moringa oleifera in metabolic disease. Asian Pac J Trop Med, 5(5): 423–427.
   39. Upadhyay, A., et al. (2022). Isothiocyanates from moringa as antiinflammatory agents. Journal of Medicinal Chemistry, 65(5):2988–3002.
   40. Rahman, H., et al. (2021). Moringa phytochemicals modulate metabolic pathways. Fitoterapia, 150: 104-156.
   41. Abdulkadir, A. (2018). Antioxidant defense mechanisms of moringa. Food Chemistry, 225: 70–77
   42. Waterhouse, A., et al. (2017). Effects of moringa on insulin resistance: clinical trial. J Diabetes Metab, 8(2): 1–6.
   43. Patel, S., et al. (2021). Effects of moringa supplementation on metabolic syndrome. Nutrients, 13(7): 2457.
   44. Olayaki, L. A., et al. (2015). Hypoglycemic effects of Moringa oleifera leaves in diabetic rats. J Basic Clin Physiol Pharmacol, 26(6):603–608.
   45. Tahiliani, P., et al. (2000). Insulin secretagogue effect of moringa leaves. Indian J Physiol Pharmacol, 44: 207–210.
   46. Kiranmai, M., et al. (2012). Moringa enhances effects of metformin. Pharmacognosy Res, 4(1): 1–5.
   47. Patel, K., et al. (2021). Phyto-pharmaceutical synergy in diabetes treatment. Biomed Pharmacother, 146: 112507.
   48. Awodele, O., et al. (2012). Toxicity profile of Moringa oleifera extracts. Nigerian J Pharmaceutical Sci, 11(2): 28–32.
   49. Kasolo, J., et al. (2011). Acute toxicity studies of moringa leaf extract. J Pharmacogn Phytother, 2(7): 89–94.
   50. Singh, R., et al. (2009). Anti-inflammatory activity of moringa. Indian J Exp Biol, 47: 354–357.
   51. Chumark, P., et al. (2008). Cardiovascular antioxidant effects of moringa. J Ethanopharmacol 116(3): 439–446.
   52. Nouman, W., et al. (2016). Potential role of M. oleifera in oxidative stress. Asian Pac J Trop Biomed, 5: 375–380.
   53. Badar, T., et al. (2019). Systems biology of phytomedicine in diabetes. Front Pharmacol 10: 841.
   54. Lee, H., et al. (2020). Omics approaches to diabetes phytomedicine. Biomed Pharmacother, 132: 110823.
   55. Vinayagam, R., et al. (2016). Nutraceutical approach in metabolic syndrome. Nutrition, 32(1): 1–5.
   56. Popoola, S. O., et al. (2021). Pharmacological activities of M. oleifera in diabetes. J Diabetes Metab 12:601.
   57. Chukwuma, C., et al. (2019). Contribution of antioxidants in diabetes management. Int J Mol Sci, 20(18): 4521.
   58. Ali, S., et al. (2017). Role of phytochemicals in oxidative stress in diabetes. Drug Discov Ther, 11(3): 116–122.
   59. Jung, U. J., et al. (2011). Oxidative stress and diabetes: novel strategies. BioFactors, 37(2): 82–91.
   60. Rhee, S. Y., et al. (2010). Epidemiology of diabetes. Diabetes Metab J, 34(1): 1–7.
   61. Zimmet, P., et al. (2001). Global epidemiology of diabetes. Nature, 414(6865): 782–787.
   62. International Diabetes Federation. (2021). Diabetes Atlas 10th Ed.
   63. WHO. (2019). Classification of diabetes mellitus.